Pediatric ID News

Missed clinic visits were linked to negative treatment outcomes among youth aged 16 to 24 years living with HIV, according to research presented at ID Week 2022.

The CDC and Council of State and Territorial Epidemiologists published a revised case definition of multisystem inflammatory syndrome in children, a potentially serious complication of SARS-CoV-2 infection.

The prevalence of bacterial infections in hospitalized infants — after rising during the first year of the COVID-19 pandemic — fell to prepandemic levels earlier this year, according to a study published in Pediatrics.

CDC researchers published a resource for providers that outlines the epidemiology and clinical features of mpox in children and adolescents and how it can be diagnosed and managed.

After a sharp increase in global malaria cases and deaths as COVID-19 spread in 2020, WHO reported that both cases and deaths remained relatively stable in 2021.

In Tanzania, pregnant women with HIV who had access to antiretroviral therapy for life had less than a 2% risk for vertical transmission, according to data published in The Lancet HIV.

The incidence of myopericarditis among adolescents and young adults who received mRNA COVID-19 vaccines is very low, according to a systemic review and meta-analysis published in JAMA Pediatrics.

The FDA on Thursday expanded its emergency use authorization of Moderna and Pfizer-BioNTech’s omicron-targeting bivalent COVID-19 boosters to include children aged as young as 6 months in the United States.

An expert in influenza is encouraging the public to get vaccinated ahead of “a tough season” during National Influenza Vaccination Week.

Pfizer and BioNTech are seeking an emergency use authorization from the FDA for omicron BA.4/BA.5-adapted bivalent COVID-19 vaccines in children aged 6 months to 4 years.